Genes to Cognition Programme, Centre for Clinical Brain Sciences, The University of Edinburgh, Chancellors Building, 47 Little France Crescent, Edinburgh EH16 4SB, United Kingdom.
Curr Opin Neurobiol. 2012 Jun;22(3):522-9. doi: 10.1016/j.conb.2012.02.002. Epub 2012 Mar 10.
The human synapse proteome is a highly complex collection of proteins that is disrupted by hundreds of gene mutations causing over 100 brain diseases. These synaptic diseases, or synaptopathies, cause major psychiatric, neurological and childhood developmental disorders through mendelian and complex genetic mechanisms. The human postsynaptic proteome and its core signaling complexes built by the assembly of receptors and enzymes around Membrane Associated Guanylate Kinase (MAGUK) scaffold proteins are a paradigm for systematic analysis of synaptic diseases. In humans, the MAGUK Associated Signaling Complexes are mutated in Autism, Schizophrenia, Intellectual Disability and many other diseases, and mice carrying orthologous mutations show relevant cognitive, social, motoric and other phenotypes. Diseases with similar phenotypes and symptom spectrums arise from disruption of complexes and interacting proteins within the synapse proteome. Classifying synaptic disease phenotypes with genetic and proteome data provides a new brain disease classification system based on molecular etiology and pathogenesis.
人类突触蛋白质组是一个高度复杂的蛋白质集合,其中数百种基因突变会破坏蛋白质组,导致 100 多种脑部疾病。这些突触疾病,或突触病,通过孟德尔和复杂的遗传机制导致主要的精神、神经和儿童发育障碍。人类突触后蛋白质组及其核心信号复合物是通过受体和酶围绕膜相关鸟苷酸激酶(MAGUK)支架蛋白组装构建的,这是系统分析突触疾病的范例。在人类中,MAGUK 相关信号复合物在自闭症、精神分裂症、智力障碍和许多其他疾病中发生突变,携带同源突变的小鼠表现出相关的认知、社交、运动和其他表型。具有相似表型和症状谱的疾病是由于突触蛋白质组内的复合物和相互作用蛋白的破坏而产生的。利用遗传和蛋白质组数据对突触疾病表型进行分类,提供了一种基于分子病因和发病机制的新的脑部疾病分类系统。